|
FAM98A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54550000003506E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.816100E-04 |
| Normal-vs-Stage2 |
1.109440E-01 |
| Normal-vs-Stage3 |
3.012400E-01 |
| Normal-vs-Stage4 |
7.429800E-01 |
| Stage1-vs-Stage2 |
9.554600E-01 |
| Stage1-vs-Stage3 |
4.924400E-01 |
| Stage1-vs-Stage4 |
1.788620E-01 |
| Stage2-vs-Stage3 |
5.881200E-01 |
| Stage2-vs-Stage4 |
1.984000E-01 |
| Stage3-vs-Stage4 |
4.088000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0998999999966E-05 |
| Normal-vs-AfricanAmerican |
3.132600E-01 |
| Normal-vs-Asian |
1.648210E-01 |
| Caucasian-vs-AfricanAmerican |
8.350200E-02 |
| Caucasian-vs-Asian |
1.140390E-01 |
| AfricanAmerican-vs-Asian |
2.186200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.98589999999399E-05 |
| Normal-vs-Female |
3.043400E-03 |
| Male-vs-Female |
5.280600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.579600E-01 |
| Normal-vs-Extreme_Weight |
1.484950E-03 |
| Normal-vs-Obese |
4.397200E-03 |
| Normal-vs-Extreme_Obese |
6.109200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.983600E-02 |
| Normal_Weight-vs-Obese |
6.362500E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.853600E-01 |
| Extreme_Weight-vs-Obese |
9.685800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.881600E-01 |
| Obese-vs-Extreme_Obese |
4.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.895800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.189200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.059480E-03 |
| Normal-vs-Age(81-100Yrs) |
4.458800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.455400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.377800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.669800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.702800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.321600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.822200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.54170000496745E-08 |
| Normal-VS-Type2 PRCC |
7.981400E-01 |
| Normal-VS-KIRP CIMP |
8.799600E-03 |
| Normal-VS-Unclassified PRCC |
1.011690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.761300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.326000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.313600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.153580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.589970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.050200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.184240E-01 |
| Normal-vs-N1 |
4.042200E-01 |
| Normal-vs-N2 |
7.989400E-01 |
| N0-vs-N1 |
6.275800E-01 |
| N0-vs-N2 |
5.133800E-01 |
| N1-vs-N2 |
5.532200E-01 |
|
|
